搜索临床试验以:抗PD-1抗体
总计6902个结果
-
LiuYing尚未招聘大肠癌 | 新辅助治疗 | 错配修复缺陷 (dMMR) | 微卫星高不稳定性 (MSI-H)中国
-
Emory UniversityNational Cancer Institute (NCI)撤销预后 IV 期乳腺癌 AJCC v8 | 脑转移性恶性肿瘤 | 转移性乳腺癌 | IV 期乳腺癌美国癌症联合委员会 (AJCC) v8
-
M.D. Anderson Cancer Center主动,不招人
-
Robert L. Ferris, MD, PhDBristol-Myers Squibb招聘中
-
Qilu Hospital of Shandong UniversityJiangsu HengRui Medicine Co., Ltd.尚未招聘
-
Sun Yat-sen UniversityChongqing University Cancer Hospital; Xiangya Hospital of Central South University; Tongji Hospital 和其他合作者招聘中
-
Liang PengGuangzhou Virotech Pharmaceutical Co., Ltd.未知晚期/转移性肝细胞癌
-
Jiangsu Cancer Institute & Hospital主动,不招人
-
The University of Texas Health Science Center at...终止
-
Pfizer终止黑色素瘤 | 软组织肉瘤 | 蕈样肉芽肿 | 乳腺癌 | 实体瘤 | 鳞状细胞癌 | 人乳头瘤病毒相关恶性肿瘤 | 默克尔细胞癌美国
-
Jacobio Pharmaceuticals Co., Ltd.Merck Sharp & Dohme LLC招聘中
-
The First Affiliated Hospital of Guangdong Pharmaceutical...University of Technology, Sydney; Guangzhou Anjie Biomedical Technology Co., Ltd.未知
-
Chinese PLA General HospitalZhejiang University招聘中淋巴瘤 | 实体瘤,成人 | EphA2 过表达 | TP53 R273H | TP53 R175H | TP53 R248Q | TP53 R249S中国
-
Huiqiang Huang招聘中高级别 B 细胞淋巴瘤 | 转化淋巴瘤 | EBV 阳性 DLBCL,编号 | ALK 阳性间变性大细胞淋巴瘤 | 非 GCB/ABC 弥漫性大 B 细胞淋巴瘤 | 滤泡性淋巴瘤 IIIb 级中国
-
Chinese PLA General HospitalZhejiang University招聘中
-
Sichuan Cancer Hospital and Research Institute尚未招聘
-
Anwita BiosciencesShanghai Junshi Bioscience Co., Ltd.招聘中
-
Third Military Medical University未知伯基特淋巴瘤 | 急性淋巴细胞白血病
-
Guangxi Medical UniversityWuzhou Red Cross Hospital; Wuhan Union Hospital, China; Yunnan Cancer Hospital; Hainan People's... 和其他合作者尚未招聘鼻咽癌 | 新辅助治疗 | PD-1抑制剂